Patent details

EP3439702 Title: CONJUGATED C1 ESTERASE INHIBITOR AND USES THEREOF

Basic Information

Publication number:
EP3439702
PCT Application Number:
US2017026001
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177194099
PCT Publication Number:
WO2017176798
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CONJUGATED C1 ESTERASE INHIBITOR AND USES THEREOF
French Title of Invention:
INHIBITEUR DE C1 ESTÉRASE CONJUGUÉ ET SES UTILISATIONS
German Title of Invention:
KONJUGIERTER C1-ESTERASE-INHIBITOR UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
04/04/2017
Grant date:
20/09/2023
EP Publication Date:
13/02/2019
PCT Publication Date:
12/10/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/09/2023
EP B1 Publication Date:
20/09/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/04/2024
Expiration date:
04/04/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/09/2023
 
 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, Japan (JP)

Inventor

1

Name:
PAN, Clark
Address:
United States (US)

2

Name:
HOLMES, Kevin
Address:
United States (US)

3

Name:
NORTON, Angela, W.
Address:
United States (US)

Priority

Priority Number:
201662318003 P
Priority Date:
04/04/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 47/60; A61K 47/61;

Publication

European Patent Bulletin

Issue number:
202338
Publication date:
20/09/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages